<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04219592</url>
  </required_header>
  <id_info>
    <org_study_id>MMC-110-19</org_study_id>
    <nct_id>NCT04219592</nct_id>
  </id_info>
  <brief_title>IgG-4 Levels in Systemic Sclerosis</brief_title>
  <acronym>SSc-IgG4</acronym>
  <official_title>Comparing IgG-4 Levels in Systemic Sclerosis Patients vs. Healthy Controls</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meir Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meir Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational - non interventional study. The investigators will compare IgG4
      levels of 80 healthy donors (from Israel blood bank - MDA) and 80 Systemic Sclerosis patients
      from Meir Medical Center.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      IgG4 levels will be obtained from medical records of 80 SSc patients between the years
      2000-2019. These will be compared to IgG4 levels from sera of 80 healthy donors (from Israel
      blood-bank - MDA). Correlations between IgG4 levels and the following will be made: age, sex,
      disease type (limited or diffused SSc), disease duration, medications.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 30, 2019</start_date>
  <completion_date type="Anticipated">February 28, 2020</completion_date>
  <primary_completion_date type="Actual">September 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>IgG4 measurement</measure>
    <time_frame>4 months</time_frame>
    <description>quantifying IgG4 in each group and in SSc subgroups based on disease type, organs involved, medications.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">154</enrollment>
  <condition>Systemic Sclerosis</condition>
  <arm_group>
    <arm_group_label>SSc</arm_group_label>
    <description>74 SSc patients aged 18 - 85</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
    <description>80 Healthy blood-donors aged 18 - 85</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>IgG4 measurement (non-interventional, just obtaining data from medical records)</intervention_name>
    <description>IgG4 measurement in mg/dL</description>
    <arm_group_label>Healthy controls</arm_group_label>
    <arm_group_label>SSc</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      sera from healthy participants purchased from MDA will be used as control.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Medical records of SSc patients from Meir Medical Center
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  SSc patients

        Exclusion Criteria:

          -  other chronic co-morbidities
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Meir Medical Center</name>
      <address>
        <city>Kfar Saba</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 5, 2020</study_first_submitted>
  <study_first_submitted_qc>January 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 7, 2020</study_first_posted>
  <last_update_submitted>January 7, 2020</last_update_submitted>
  <last_update_submitted_qc>January 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Meir Medical Center</investigator_affiliation>
    <investigator_full_name>Noa Rabinowicz</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>SSc</keyword>
  <keyword>IgG4</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Scleroderma, Systemic</mesh_term>
    <mesh_term>Scleroderma, Diffuse</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>not relevant</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

